miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3

Numerous studies have been conducted to demonstrate that miRNA is strongly related to colon cancer progression. Nevertheless, there are few studies regarding the function for miR-1266-3p in colon cancer, and the molecular mechanism remains poorly know. Our study was designed to examine the level of...

Full description

Saved in:
Bibliographic Details
Main Authors: Hailang Zhou, Shu Huang, Changjiang Shao, Junwei Zou, Aijun Zhou, Jiufeng Yu, Chunfang Xu
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Analytical Cellular Pathology
Online Access:http://dx.doi.org/10.1155/2022/1542117
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850179118037991424
author Hailang Zhou
Shu Huang
Changjiang Shao
Junwei Zou
Aijun Zhou
Jiufeng Yu
Chunfang Xu
author_facet Hailang Zhou
Shu Huang
Changjiang Shao
Junwei Zou
Aijun Zhou
Jiufeng Yu
Chunfang Xu
author_sort Hailang Zhou
collection DOAJ
description Numerous studies have been conducted to demonstrate that miRNA is strongly related to colon cancer progression. Nevertheless, there are few studies regarding the function for miR-1266-3p in colon cancer, and the molecular mechanism remains poorly know. Our study was designed to examine the level of miR-1266-3p expression among the colon cancer tissue and cell and to study the role and regulatory mechanism for miR-1266-3p among colon cancer’s malignant biologic behavior. First, we found that miR-1266-3p expression was distinctly lower in colonic carcinoma tissues and cells than in nontumor ones, and the prognosis of low miR-1266-3p patients was distinctly worse than that of high miR-1266-3p patients. Second, we predicted that the target gene of miR-1266-3p was prolyl 4-hydroxylase subunit alpha 3 (P4HA3) through bioinformatics, and the targeting relationship between the two was verified by a dual luciferase assay report. Furthermore, miR-1266-3p inhibited the growth and metastasis of colon cancer in vitro as well as in vivo, and this effect could be alleviated by overexpressing P4HA3. Even more importantly, our study demonstrated that miR-1266-3p inhibited epithelial-mesenchymal transition (EMT) by targeting P4HA3. In conclusion, miR-1266-3p could inhibit growth, metastasis, and EMT in colon cancer by targeting P4HA3. Our discoveries might offer a novel target for colon cancer diagnosis and treatment.
format Article
id doaj-art-be7858ef674a4c4b9cd8e6b8a103c4b7
institution OA Journals
issn 2210-7185
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Analytical Cellular Pathology
spelling doaj-art-be7858ef674a4c4b9cd8e6b8a103c4b72025-08-20T02:18:35ZengWileyAnalytical Cellular Pathology2210-71852022-01-01202210.1155/2022/1542117miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3Hailang Zhou0Shu Huang1Changjiang Shao2Junwei Zou3Aijun Zhou4Jiufeng Yu5Chunfang Xu6Department of GastroenterologyDepartment of GastroenterologyDepartment of GastroenterologyDepartment of General SurgeryDepartment of GastroenterologyDepartment of Traditional Chinese MedicineDepartment of GastroenterologyNumerous studies have been conducted to demonstrate that miRNA is strongly related to colon cancer progression. Nevertheless, there are few studies regarding the function for miR-1266-3p in colon cancer, and the molecular mechanism remains poorly know. Our study was designed to examine the level of miR-1266-3p expression among the colon cancer tissue and cell and to study the role and regulatory mechanism for miR-1266-3p among colon cancer’s malignant biologic behavior. First, we found that miR-1266-3p expression was distinctly lower in colonic carcinoma tissues and cells than in nontumor ones, and the prognosis of low miR-1266-3p patients was distinctly worse than that of high miR-1266-3p patients. Second, we predicted that the target gene of miR-1266-3p was prolyl 4-hydroxylase subunit alpha 3 (P4HA3) through bioinformatics, and the targeting relationship between the two was verified by a dual luciferase assay report. Furthermore, miR-1266-3p inhibited the growth and metastasis of colon cancer in vitro as well as in vivo, and this effect could be alleviated by overexpressing P4HA3. Even more importantly, our study demonstrated that miR-1266-3p inhibited epithelial-mesenchymal transition (EMT) by targeting P4HA3. In conclusion, miR-1266-3p could inhibit growth, metastasis, and EMT in colon cancer by targeting P4HA3. Our discoveries might offer a novel target for colon cancer diagnosis and treatment.http://dx.doi.org/10.1155/2022/1542117
spellingShingle Hailang Zhou
Shu Huang
Changjiang Shao
Junwei Zou
Aijun Zhou
Jiufeng Yu
Chunfang Xu
miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3
Analytical Cellular Pathology
title miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3
title_full miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3
title_fullStr miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3
title_full_unstemmed miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3
title_short miR-1266-3p Suppresses Epithelial-Mesenchymal Transition in Colon Cancer by Targeting P4HA3
title_sort mir 1266 3p suppresses epithelial mesenchymal transition in colon cancer by targeting p4ha3
url http://dx.doi.org/10.1155/2022/1542117
work_keys_str_mv AT hailangzhou mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3
AT shuhuang mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3
AT changjiangshao mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3
AT junweizou mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3
AT aijunzhou mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3
AT jiufengyu mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3
AT chunfangxu mir12663psuppressesepithelialmesenchymaltransitionincoloncancerbytargetingp4ha3